Investigating kidney injury related to sepsis
Official title: Investigations Into the Mechanisms for Bioenergetic Failure in Sepsis-associated Acute Kidney Injury
Run by University Hospital of North Norway · NCT05694624 · Data updated 2026-11-12
This study looks at how sepsis affects kidney function and energy use in patients with kidney injury compared to healthy people having surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospital of North Norway Academic / other |
| Locations | 1 site (Tromsø, Troms) |
| Status | Recruiting |
| Started | August 14, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 21, 2025 |
| Trial ID | NCT05694624 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed or suspected of having sepsis with normal premorbid serum creatinine levels.
✕Probably not a fit
Patients with pre-existing kidney conditions or those not diagnosed with sepsis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the metabolic and hemodynamic disturbances in patients experiencing sepsis-associated acute kidney injury (AKI) compared to healthy controls undergoing laparoscopic abdominal surgery. The researchers will investigate renal metabolism and bioenergetics, focusing on the activity of specific enzymes and metabolites related to energy supply in the kidneys. By analyzing variables such as renal oxygenation, glomerular filtration rate, and mitochondrial respiration, the study seeks to enhance understanding of the pathobiology of sepsis-associated AKI and its potential causes.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of acute kidney injury in septic patients, potentially reducing mortality rates.
How similar studies have gone: While there have been studies on acute kidney injury, this specific investigation into the metabolic pathways related to sepsis-associated AKI is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria sepsis group: * Sepsis diagnosed or suspected * Normal premorbid serum creatinine measured or anticipated (if data are not available) * Normovolemia as indicated by a pulse pressure variation less than 12% Comparator group * Previously healthy individuals scheduled for laparoscopic colon cancer resection * Normal creatinine levels within 3 months before admittance to hospital. * Patients admitted to the intensive care unit with sepsis diagnosed or suspected * Previously healthy patients listed for elective colon cancer surgery Exclusion Criteria: \-
Where it's running
-
University Hospital of North Norway
Tromsø, Troms, Norway Recruiting
Study contacts
- Principal investigator: Lars MG Ytrebø — University Hospital of North Norway
- Study coordinator: Lars M Ytrebo, MD PhD
- Email: lars.marius.ytrebo@unn.no
- Phone: +4790788058
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery
This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Biomarkers to predict CSA-AKI risk before heart surgery
This study tests new biomarkers to see if they can predict CSA-AKI risk in adults undergoing cardiovascular surgery.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Perioperative GFR Monitoring to Predict CSA-AKI and CA-AKI
This study tests whether perioperative transcutaneous fluorescence GFR measurements can predict CSA-AKI or CA-AKI in adults undergoing cardiovascular procedures or iodine contrast exposure.
-
Restarting RAS inhibitors after AKI: a quick test in hospitalized adults
This pilot study tests whether restarting renin-angiotensin system inhibitors early after acute kidney injury is feasible and safe in hospitalized adults already using these medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.